20-F/A: EUDA Health Reports Deepening Losses, Going Concern Doubts

EUDA Health Holdings Limited filed an amended annual report for 2024, revealing a significant net loss, accumulated deficit, and substantial doubt about its ability to continue as a going concern, despite a strategic shift to holistic wellness.

Summary

• Amendment No. 2 to the 20-F for the year ended December 31, 2024, primarily restates financial statements and updates CEO and CFO certifications and auditor consents.
• The company reported a net loss attributable to EUDA Health Holdings Limited of $(15,357,156) for 2024, compared to $(10,039,481) in 2023 and $(24,884,122) in 2022.
• Total revenues increased to $4,011,005 in 2024 from $3,706,458 in 2023, driven by the new holistic wellness segment.
• Gross profit decreased to $762,155 in 2024 from $842,075 in 2023.
• Operating expenses surged to $18,097,286 in 2024 from $4,803,129 in 2023, primarily due to a $14,755,560 impairment loss on intangible assets related to the Fortress Cove acquisition.
• The company recorded an accumulated deficit of $50,100,426 and a shareholders deficit of $2,553,059 as of December 31, 2024.
• A working capital deficit of approximately $3.4 million was reported as of December 31, 2024.
• The company completed the acquisition of Fortress Cove Limited on May 8, 2024, for 8,571,428 ordinary shares valued at $15.0 million, marking a strategic shift into holistic wellness consumer products and services.
• Medical service operations were streamlined and largely discontinued in 2023 and 2024, with several subsidiaries deconsolidated or sold, resulting in a net income from discontinued operations of $2,246,340 in 2024.

Sentiment

Score: 2

Explanation: The company's financial health is severely deteriorated, evidenced by deepening net losses, a substantial accumulated deficit, and explicit 'going concern' doubts from auditors and management. While revenues increased, this was overshadowed by a massive impairment charge and ongoing liquidity issues. The strategic shift is costly and its success is uncertain.

Positives

• Total revenues increased to $4,011,005 in 2024 from $3,706,458 in 2023, indicating growth in the new business segments.
• Net income from discontinued operations was $2,246,340 in 2024, a positive reversal from a loss of $(1,601,323) in 2023.
• The acquisition of Fortress Cove Limited expands the company's presence in the holistic wellness consumer products and services market in Malaysia, Vietnam, and Indonesia.

Negatives

• The company reported a significant net loss attributable to EUDA Health Holdings Limited of $(15,357,156) in 2024, a worsening from $(10,039,481) in 2023.
• Operating expenses dramatically increased to $18,097,286 in 2024, largely due to a $14,755,560 impairment loss on intangible assets related to the Fortress Cove acquisition.
• Gross profit declined to $762,155 in 2024 from $842,075 in 2023.
• The company has an accumulated deficit of $50,100,426 and a shareholders deficit of $2,553,059 as of December 31, 2024.
• A working capital deficit of approximately $3.4 million as of December 31, 2024, highlights liquidity challenges.
• Recurring losses from operations and negative cash flows from operating activities have persisted since 2020.
• Management assessed the probability of achieving contingent consideration milestones for the Fortress Cove acquisition as "very unlikely," resulting in a $0 fair value for the additional shares.

Risks

• Going Concern: The company has generated recurring losses, suffered an accumulated deficit of $50,100,426, and a shareholders deficit of $2,553,059 as of December 31, 2024, raising substantial doubt about its ability to continue as a going concern.
• Liquidity Risk: A working capital deficit of approximately $3.4 million and negative cash flows from operating activities indicate an ongoing need to raise additional cash from outside sources.
• Financing Risk: No assurances that required financings will be available for the amounts needed or on commercially acceptable terms.
• Acquisition Integration Risk: The significant impairment loss of $14,755,560 on intangible assets related to the Fortress Cove acquisition suggests potential challenges in realizing expected value from the acquisition.
• Legal Proceedings: The company is involved in legal disputes concerning director appointments and removals, and a statutory demand for $138,202.66 from a legal firm, which could have an adverse effect on business and financial condition.
• Operational Transition Risk: The strategic shift from medical services to holistic wellness consumer products and services involves inherent risks in establishing new operations and market acceptance.
• Contingent Consideration Risk: The unlikelihood of achieving financial performance milestones for the Fortress Cove acquisition means the additional 1 million ordinary shares may not be issued, potentially impacting seller incentives.
• Foreign Currency Translation Risk: The company operates in Singapore (SGD) and Malaysia (MYR), exposing it to foreign currency translation adjustments.
• Credit Risk: Exposure to credit risk from cash held in banks and accounts receivable, although management monitors creditworthiness and maintains allowances.
• Concentration Risk: While no single customer accounted for more than 10% of total revenues in 2024, two customers accounted for 19.0% and 15.0% of accounts receivable, respectively, as of December 31, 2024.

Future Outlook

Management acknowledges substantial doubt about the company's ability to continue as a going concern and plans to seek additional financing from Singapore banks, financial institutions, private lenders, or through equity financing. The company is transitioning its business focus to holistic wellness consumer products and services following the streamlining of its medical services practice.

Management Comments

• "Management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that our consolidated financial statements are issued."
• "The Company can make no assurances that required financings will be available for the amounts needed, or on terms commercially acceptable to the Company, if at all."
• "Management is trying to alleviate the going concern risk by securing various financing resources, including but not limited to borrowing from the Company's shareholders and certain of their affiliates, as well as the possibility of raising funds through a future public offering."
• "Based on the financial forecast of CKHP, CKHP forecasted the probability of achieving the Milestones [for contingent consideration] is very unlikely in Fiscal Year 2024 and Fiscal Year 2025."

Industry Context

The company's strategic shift from medical services to holistic wellness consumer products and services aligns with a growing global trend towards preventative health and personal well-being. However, the significant impairment loss on intangible assets from the Fortress Cove acquisition suggests potential challenges in executing this transition or overvaluation of acquired assets in a competitive market. The company operates primarily in Singapore and Malaysia, markets with evolving healthcare and wellness landscapes.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• Disagreements between directors and former directors concerning the legitimacy of appointments, removals, and shareholder resolutions, which the Board determined were prima facie invalid.
• KRHSG (a former subsidiary) filed a claim against Mr. Capes and another defendant in July 2023 for unlawfully obstructed access to client and clinic management systems, causing business disruption and losses.
• A statutory demand for US$138,202.66 was served by Carey Olsen Singapore LLP on May 10, 2024, for alleged legal services. The company disputes liability and filed an application to set aside the demand, with a hearing scheduled for May 1, 2025.

Related Party Transactions

• Acquisition of Fortress Cove Limited on May 6, 2024, where Meng Dong (James) Tan, a significant shareholder of EUDA, was also a 40% shareholder of Fortress Cove before the acquisition.
• Consultancy Agreement with 8i Enterprises Pte Ltd (owned by Mr. Tan) for merger and acquisition advisory services, with $135,000 accrued as of December 31, 2024.
• IT professional consulting services from 8i Digital (shareholders also shareholders of the Company) for $21,952 from August to October 2024.
• Short-term loans from related parties: Meng Dong (James) Tan, Alfred Lim (CEO), and 8i Enterprises Pte. Ltd. totaling $438,097 as of December 31, 2024.
• Convertible notes from related parties: 8i Enterprises Pte. Ltd and Meng Dong (James) Tan totaling $46,377 as of December 31, 2024.
• Subsequent loan agreements (Jan-Apr 2025) with 8i Enterprises Pte Ltd for $768,942 and Alfred Lim for $35,855.
• Convertible Note Extension Agreement for 8iEPL and James Tan Convertible Notes to December 31, 2025, with no interest.

Stakeholder Impact

• Shareholders: Significant dilution from share issuances for acquisitions and debt conversions (37,153,049 shares outstanding as of Dec 31, 2024, up from 24,627,509 in 2023). Accumulated deficit and going concern doubts pose substantial risk to shareholder value.
• Creditors/Lenders: The company's recurring losses, accumulated deficit, and working capital deficit increase credit risk. Convertible notes and short-term loans from private and related parties indicate reliance on non-traditional financing.
• Employees: Management changes and settlements for former executives, along with the streamlining of medical services, could impact employee morale and stability. Defined contribution plans are in place.
• Customers: The strategic shift to holistic wellness and discontinuation of medical services may affect existing medical service customers, while new wellness customers are being targeted.
• Suppliers: The company's financial instability could impact its ability to meet obligations to suppliers, although no major vendor concentration risk was identified for purchases.

Next Steps

• Secure additional financing from Singapore banks, financial institutions, private lenders, or through equity financing to address going concern risk.
• Continue the strategic transition to holistic wellness consumer products and services.
• Address legal proceedings, including the originating application to set aside the statutory demand from Carey Olsen, with a hearing listed for May 1, 2025.
• Complete the conversion of convertible notes held by Sarina Binti Md Amin and Rosli Bin Abd Latif into ordinary shares.

Key Dates

Recommendation

The company's financial health is severely deteriorated, marked by a substantial net loss of over $15 million in 2024, a massive accumulated deficit exceeding $50 million, and a working capital deficit. The auditors explicitly raised 'substantial doubt about the Company's ability to continue as a going concern.' While revenues saw a modest increase, this was overshadowed by a significant impairment loss on intangible assets from a recent acquisition, suggesting poor asset valuation or integration challenges. The reliance on related-party financing and the uncertainty of securing future capital further exacerbate the risk profile. Given the persistent losses, liquidity issues, and fundamental going concern risk, the stock represents a strong sell for investors.

Keywords

EUDA Health Holdings, SEC Filing, 20-F/A, Annual Report, Financial Results, Net Loss, Going Concern, Holistic Wellness, Property Management, Fortress Cove Acquisition, Impairment Loss, Shareholders Deficit, Working Capital Deficit, Convertible Notes, Related Party Transactions, Legal Proceedings, Singapore, Malaysia, Nasdaq